A systematic review and economic model of the effectiveness and ...

140
References
165. Aman MG, Langworthy KS. Pharmacotherapy for
hyperactivity in children with autism and other
pervasive developmental disorders. J Autism Dev
Disord 2000;30:451–9.
166. Aman MG, Buican B, Arnold LE. Methylphenidate
treatment in children with borderline IQ and
mental retardation: analysis of three aggregated
studies. J Child Adolesc Psychopharmacol
2003;13:29–40.
167. Baren M, Swanson JM, Wigal SB. Lack of effect of
different breakfast conditions on the
pharmacokinetics and efficacy of OROS ®
methylphenidate HCl extended-release tablets in
children with ADHD. Pediatr Res 2000;47:129.
168. Bedard AC, Ickowicz A, Tannock R.
Methylphenidate improves Stroop naming speed,
but not response interference, in children with
attention deficit hyperactivity disorder. J Child
Adolesc Psychopharmacol 2002;12:301–9.
169. Bedard AC, Martinussen R, Ickowicz A, Tannock
R. Methylphenidate improves visual-spatial
memory in children with attentiondeficit/hyperactivity
disorder. J Am Acad Child
Adolesc Psychiatry 2004;43:260–8.
170. Berman T. Effects of methylphenidate on complex
cognitive processing in attention-deficit hyperactivity
disorder. Thesis. Montreal: McGill University; 1998.
171. Berman T, Douglas VI, Barr RG. Effects of
methylphenidate on complex cognitive processing
in attention-deficit hyperactivity disorder. J Abnorm
Psychol 1999;108:90–105.
172. Biederman J. Effectiveness and safety of the oncedaily
OROS formulation of methylphenidate in
adolescents with attention-deficit/hyperactivity
disorder. Eur Neuropsychopharmacol 2003;13:S448.
173. Biederman J. Evaluation of once-daily OROS
methylphenidate in children with attentiondeficit/hyperactivity
disorder: effects on sleep,
appetite, and tics. Eur Neuropsychopharmacol
2003;13 (suppl 4):S447–8.
174. Biederman J, Quinn D, Weiss M, Markabi S,
Weidenman M, Edson K, et al. Efficacy and safety
of Ritalin LA, a new, once daily, extended-release
dosage form of methylphenidate, in children with
attention deficit hyperactivity disorder. Paediatr
Drugs 2003;5:833–41.
175. Caballero J, Nahata MC. Atomoxetine
hydrochloride for the treatment of attentiondeficit/hyperactivity
disorder. Clin Ther
2003;25:3065–83.
176. Chen J, Chen YY, Wang XM. Clinical study on
treatment of children attention deficit
hyperactivity disorder by jiangqian granule.
Zhongguo Zhong Xi Yi Jie He Za Zhi
2002;22:258–60.
177. Chronis AM, Pelham WEJR, Gnagy EM,
Roberts JE, Aronoff HR. The impact of lateafternoon
stimulant dosing for children with
ADHD on parent and parent–child domains. J Clin
Child Adolesc Psychol 2003;32:118–26.
178. Connor DF. Preschool attention deficit
hyperactivity disorder: a review of prevalence,
diagnosis, neurobiology, and stimulant treatment.
J Dev Behav Pediatr 2002;23 (Suppl 1):S1–9.
179. Connor DF, Barkley RA, Davis HT. A pilot study of
methylphenidate, clonidine, or the combination in
ADHD comorbid with aggressive oppositional
defiant or conduct disorder. Clin Pediatr
2000;39:15–25.
180. Cox DJ, Merkel RL, Penberthy JK, Kovatchev B,
Hankin CS. Impact of methylphenidate delivery
profiles on driving performance of adolescents
with attention-deficit/hyperactivity disorder: a pilot
study. J Am Acad Child Adolesc Psychiatry
2004;43:269–75.
181. Davidovitch M, Manning-Courtney P,
Hartmann LA, Watson J, Lutkenhoff M,
Oppenheimer S. The prevalence of attentional
problems and the effect of methylphenidate in
children with myelomenigocele. Pediatr Rehabil
1999;3:29–35.
182. Denney CB, Rapport MD. Predicting
methylphenidate response in children with ADHD:
theoretical, empirical, and conceptual models.
J Am Acad Child Adolesc Psychiatry 1999;38:393–401.
183. Ding GA, Yu GH, Chen SF. Assessment on effect of
treatment for childhood hyperkinetic syndrome by
combined therapy of yizhi mixture and ritalin.
Zhongguo Zhong Xi Yi Jie He Za Zhi 2002;22:255–7.
184. Donnelly M, Rapoport JL, Potter WZ, Oliver J,
Keysor CS, Murphy DL. Fenfluramine and
dextroamphetamine treatment of childhood
hyperactivity: clinical and biochemical findings.
Arch Gen Psychiatry 1989;46:205–12.
185. Duggan CM, Mitchell G, Nikles CJ, Glasziou PP,
Del Mar CB, Clavarino A. Managing ADHD in
general practice. N of 1 trials can help! Aust Fam
Physician 2000;29:1205–9.
186. Ebell M. How safe and effective is short-acting
methylphenidate for the treatment of attentiondeficit
disorder in children and adolescents? Evid
Based Pract 2002;5:9.
187. Eiland LS, Guest AL. Atomoxetine treatment of
attention-deficit/hyperactivity disorder. Ann
Pharmacother 2004;38:86–90.
188. Firestone P, Musten LM, Pisterman S, Mercer J,
Bennett S. Short-term side effects of stimulant
medication are increased in preschool children
with attention-deficit/hyperactivity disorder: a
double-blind placebo-controlled study. J Child
Adolesc Psychopharmacol 1998;8:13–25.